Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Alteogen (196170) – Daishin Securities | Key US Patent Risks Significantly Eased · New Licensing Catalysts · Keytruda SC Milestones / 2026-06-02 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Valuation Reset · MLCC Price Hikes · Server Demand / 2026-07-31 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Order Recovery · Plant Ramp-up · Earnings Growth / 2026-07-24 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Memory ASP · Server Demand · Earnings Upgrades / 2026-03-31 Research
  • [Research] Samsung SDI (006400) – IBK Securities | ESS Shipment Expansion · AMPC Benefits · Profit Turnaround / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Long-Term Contracts · HBM4 / 2026-01-14 Research
  • [IR] Samsung Electronics (005930) – Q1 2026 Earnings Presentation / 2026-04-30 IR Room

[Research] Hanwha Ocean (042660) – Yuanta | Merchant Vessel Margin · FX Gains · Earnings Differentiation / 2026-07-28

Posted on July 28, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : Yuanta Securities

Analyst : Yongmin Kim

Investment Rating : BUY (Maintained)

Target Price : KRW 179,000 (Maintained)

Core Momentum : Differentiated earnings growth driven by expanding revenue recognition of high-price FY24–25 orders and recurring FX gains under a limited hedging policy during periods of Won weakness

📊 1. [Valuation & Key Financial Metrics]

  • Rating & Target Price: BUY Maintained based on SOTP valuation, Target Price maintained at KRW 179,000 (Current Price: KRW 88,800 as of July 27, 2026; Upside potential: 102%)
  • 2Q26 Earnings Summary: Revenue came in at KRW 5.44 trillion (+65.2% YoY, +69.6% QoQ), Operating Profit stood at KRW 736.0 billion (+98.0% YoY, +66.9% QoQ, OPM 13.5%), and Net Profit attributable to controlling interests reached KRW 810.0 billion (+445.7% YoY, +62.0% QoQ), significantly beating consensus (operating profit of KRW 534.0 billion) and the brokerage’s prior estimate (KRW 586.0 billion).
  • Key Forecast Financials (2025A → 2026F → 2027F):
    • Revenue: KRW 12.78 trillion → KRW 15.96 trillion → KRW 16.05 trillion
    • Operating Profit: KRW 1.17 trillion → KRW 2.68 trillion → KRW 3.26 trillion
    • Net Profit (Controlling): KRW 1.25 trillion → KRW 3.41 trillion → KRW 3.15 trillion
    • PER: 20.3x → 8.0x → 8.7x
    • PBR: 4.1x → 2.8x → 2.1x
    • ROE: 22.6% → 43.3% → 28.1%
    • EV/EBITDA: 21.6x → 9.7x → 7.0x

🚀 2. [Market Opportunities & Business Outlook]

  • Merchant Division Drives Earnings Surge: In 2Q26, the merchant shipbuilding division posted an operating profit of KRW 735.6 billion (OPM 22.7%). Excluding ~KRW 1.5 trillion in one-off offshore project delivery revenue (which had limited profit impact), merchant operations drove the overall surprise. Key differentiation factors versus peers include: 1) higher sales mix of high-price orders secured in FY24–25, and 2) full realization of FX translation gains stemming from KRW depreciation under a limited hedging policy.
  • Recurring Mechanism of FX Gains: Following 1Q26, substantial FX translation gains contributed to 2Q26 profits. As order-intake exchange rates were below KRW 1,400, this spread represents one-off gains that can recur as long as the Korean Won remains weak, reinforcing organic profitability improvements.
  • Downside Support Factors: Solid profitability driven by expanding revenue recognition of FY24–25 order vintages, alongside recurring FX gains (barring a sharp drop in USD/KRW toward KRW 1,400), will provide robust fundamental downside support for the stock in 2H26 in addition to US-Korea shipbuilding cooperation themes.

📝 Editor’s Comment (Perspective)

The analyst views Hanwha Ocean as a shipbuilder demonstrating differentiated earnings performance versus peers, driven by the combination of high-price order mix recognition and recurring FX translation gains under a limited hedging policy in a weak-Won environment. This perspective emphasizes the compounded effect of organic profitability gains from high-value contracts and the continued benefit of currency translation as long as foreign exchange conditions remain favorable.

To evaluate whether this investment thesis continues to materialize, key verification points include whether merchant vessel operating margins remain near the 20% level as FY24–25 orders expand in the revenue mix, the persistence of FX-driven profit contributions across upcoming quarterly results, and tangible contract progress in US-Korea naval collaboration projects. These factors can be monitored through future quarterly earnings releases, official IR materials, regulatory filings, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Shipbuilding

Post navigation

Previous Post: [Research] Hanwha Ocean (042660) – Hana Securities | Merchant Vessel Margin Expansion · Energy Supply Chain Shift · Order Momentum / 2026-07-28
Next Post: [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28

Related Posts

  • [Research] SK hynix (000660 / SKHY) – Meritz | ADR Listing · Valuation Discount · Re-rating / 2026-04-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | AI MLCC Shortage · FC-BGA Margin Expansion · Earnings Direction / 2026-07-31 Research
  • [Research] Alteogen (196170) – Shinhan Securities | First UK Patent Ruling Favors Merck · Positive Read-across to Global Disputes · Pipeline Out-Licensing Ahead / 2026-02-23 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Agentic AI · Memory Demand · Cycle Stability / 2026-05-13 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | HBM4 · LTA · Valuation Appeal / 2026-07-30 Research
  • [Research] Celltrion (068270) – Shinhan Securities | New Product Sales Expansion · Operating Leverage · Global CMO Contracts / 2026-05-15 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Legacy Memory Pricing · LTA · ADR / 2026-02-23 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | Core Profitability Turnaround · Robust ESS Backlog · Humanoid Physical AI Expansion / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Server Demand · Earnings Upgrades / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Server DRAM · eSSD · Earnings Upgrades / 2026-04-09 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · Earnings Floor · Cycle Stability / 2026-07-30 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Alteogen (196170) – Hana Securities | Steady Milestone Inflows · Interpreting GSK’s Enhanze Deal · PGR Final Ruling Catalysts / 2026-05-13 Research
  • [Research] Samsung SDI (006400/KS) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme